BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37654056)

  • 1. Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiation Between Recurrence and Pseudoprogression in High-Grade Glioma: A Meta-analysis.
    Gu X; He X; Wang H; Li J; Chen R; Liu H
    J Comput Assist Tomogr; 2024 Mar-Apr 01; 48(2):303-310. PubMed ID: 37654056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiating Recurrence From Radiation Injury in Postoperative Glioma: A Meta-analysis.
    Zhang HM; Huo XB; Wang HL; Wang C
    J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):938-944. PubMed ID: 35969866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
    Yu Y; Ma Y; Sun M; Jiang W; Yuan T; Tong D
    Medicine (Baltimore); 2020 Jun; 99(23):e20270. PubMed ID: 32501974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis.
    Wan B; Wang S; Tu M; Wu B; Han P; Xu H
    Medicine (Baltimore); 2017 Mar; 96(11):e6333. PubMed ID: 28296759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis.
    Zhang L; Min Z; Tang M; Chen S; Lei X; Zhang X
    J Neurol Sci; 2017 Feb; 373():9-15. PubMed ID: 28131237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.
    Zhang J; Wang Y; Wang Y; Xiao H; Chen X; Lei Y; Feng Z; Ma X; Ma L
    Quant Imaging Med Surg; 2022 Oct; 12(10):4805-4822. PubMed ID: 36185045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging for distinguishing pseudoprogression from glioma recurrence: a meta-analysis.
    Qiu J; Tao ZC; Deng KX; Wang P; Chen CY; Xiao F; Luo Y; Yuan SY; Chen H; Huang H
    Chin Med J (Engl); 2021 Oct; 134(21):2535-2543. PubMed ID: 34748524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of ADC derived from DWI for differentiating high-grade from low-grade gliomas: Systematic review and meta-analysis.
    Wang QP; Lei DQ; Yuan Y; Xiong NX
    Medicine (Baltimore); 2020 Feb; 99(8):e19254. PubMed ID: 32080132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
    Boxerman JL; Ellingson BM; Jeyapalan S; Elinzano H; Harris RJ; Rogg JM; Pope WB; Safran H
    Am J Clin Oncol; 2017 Jun; 40(3):228-234. PubMed ID: 25436828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.
    Du X; He Y; Lin W
    Front Neurol; 2022; 13():882334. PubMed ID: 35812103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of arterial spin labeling for preoperative grading of glioma.
    Fu J; Li L; Wang X; Zhang M; Zhang Y; Li Z
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    Eur Radiol; 2018 Sep; 28(9):3819-3831. PubMed ID: 29619517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Susceptibility-Weighted Imaging and Dynamic Susceptibility Contrast Magnetic Resonance Imaging for Differentiating High-Grade Glioma from Primary Central Nervous System Lymphomas: Meta-Analysis.
    Wu Y; Den Z; Lin Y
    World Neurosurg; 2018 Apr; 112():e617-e623. PubMed ID: 29371168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation Between True Tumor Progression of Glioblastoma and Pseudoprogression Using Diffusion-Weighted Imaging and Perfusion-Weighted Imaging: Systematic Review and Meta-analysis.
    Tsakiris C; Siempis T; Alexiou GA; Zikou A; Sioka C; Voulgaris S; Argyropoulou MI
    World Neurosurg; 2020 Dec; 144():e100-e109. PubMed ID: 32777397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.
    Jung SC; Yeom JA; Kim JH; Ryoo I; Kim SC; Shin H; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH; Choi SH
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1103-10. PubMed ID: 24384119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of dynamic contrast-enhanced perfusion MRI in stratifying gliomas: A systematic review and meta-analysis.
    Okuchi S; Rojas-Garcia A; Ulyte A; Lopez I; Ušinskienė J; Lewis M; Hassanein SM; Sanverdi E; Golay X; Thust S; Panovska-Griffiths J; Bisdas S
    Cancer Med; 2019 Sep; 8(12):5564-5573. PubMed ID: 31389669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.
    Shen N; Zhao L; Jiang J; Jiang R; Su C; Zhang S; Tang X; Zhu W
    J Magn Reson Imaging; 2016 Sep; 44(3):620-32. PubMed ID: 26880230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.